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Schizophrenia etiology is thought to involve an interaction between genetic and
environmental factors during postnatal brain development. However, there is a
fundamental gap in our understanding of the molecular mechanisms by which
environmental factors interact with genetic susceptibility to trigger symptom onset and
disease progression. In this review, we summarize the most recent findings implicating
oxidative stress as one mechanism by which environmental insults, especially early life
social stress, impact the development of schizophrenia. Based on a review of the literature
and the results of our own animal model, we suggest that environmental stressors
such as social isolation render parvalbumin-positive interneurons (PVIs) vulnerable to
oxidative stress. We previously reported that social isolation stress exacerbates many
of the schizophrenia-like phenotypes seen in a conditional genetic mouse model in which
NMDA receptors (NMDARs) are selectively ablated in half of cortical and hippocampal
interneurons during early postnatal development (Belforte et al., 2010). We have since
revealed that this social isolation-induced effect is caused by impairments in the
antioxidant defense capacity in the PVIs in which NMDARs are ablated. We propose
that this effect is mediated by the down-regulation of PGC-1α, a master regulator of
mitochondrial energy metabolism and anti-oxidant defense, following the deletion of
NMDARs (Jiang et al., 2013). Other potential molecular mechanisms underlying redox
dysfunction upon gene and environmental interaction will be discussed, with a focus on
the unique properties of PVIs.
Keywords: animal model, fast-spiking neurons, GABA neuron, NMDA receptors, oxidative stress, PGC-1α, social
isolation
INTRODUCTION
Schizophrenia is a chronic and complex neuropsychiatric disorder
that affects approximately 1% of the population worldwide (Insel,
2010). The characteristic features of schizophrenia have been cat-
egorized into three major symptom domains (DSM-IV, American
Psychiatric Association, 1994). Positive symptoms are psychotic
behaviors not seen in healthy people, such as hallucillations,
delusions, disorganized thinking, andmovement disorders which,
in part, can be relieved through the use of current antipsychotic
medications. Negative symptoms are associated with disruption
of normal emotions and behaviors, such as motivational impair-
ment (avolition or amotivation), affective dysregulation (depres-
sion, mania), and social withdrawal. Cognitive symptoms include
poor executive functioning, trouble focusing or paying attention,
and problems with working memory. The onset of symptoms
usually occurs during late adolescence and early adulthood.
Based on classical family, twin and adoption studies, genetic
theories of schizophrenia etiology have been prominent since
1960s (Gottesman and Shields, 1976; Cardno and Gottesman,
2000; Carter et al., 2002; Sullivan et al., 2003; Tienari et al., 2004;
Lichtenstein et al., 2009). Early linkage studies produced the first
list of gene candidates, and a large body of gene association work
identified some of these candidate genes as true susceptibility
factors (Owen et al., 2005; Ross et al., 2006; Straub and Wein-
berger, 2006). Recently, analysis of data generated using genome-
wide mass-marker technology (such as genome-wide association
studies (GWAS) and next generation sequencing) has raised the
possibility that thousands of common polymorphisms (Purcell
et al., 2009) and multiple rare copy-number variations (CNVs) in
several different genomic areas contribute to schizophrenia risk
(Stefansson et al., 2008; Stone et al., 2008; Walsh et al., 2008; Xu
et al., 2008; McCarthy et al., 2009; Ingason et al., 2011). Although
GWAS from the psychiatric genomics consortium (PGC), a col-
laboration across more than 300 scientists in 80 institutions and
20 countries, have been carried out to investigate a large number
of polymorphisms from thousands of patients (61,220 subjects,
Smoller et al., 2013), no single gene or allele has independently
been identified as a key risk factor in a large number of people.
One plausible explanation for the weak association of
schizophrenia with an individual gene is that genetic risk is
critically dependent on environmental context. A considerable
body of evidence suggests that an interaction between genetic
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vulnerability and environmental factors (GxE) leads to the
manifestation of schizophrenia. Even monozygotic twins who
share identical genes have a concordance rate of 41–65% (Cardno
and Gottesman, 2000). Epidemiologic studies suggest that
a diversity of factors, including prenatal infection/immune
activation, paternal age, malnutrition, hypoxia-related obstetric
complications, and childhood/adolescence social stress and
cannabis abuse, are associated with an increased risk for the
development of this disorder (see reviews, Barkus and Murray,
2010; van Os et al., 2010; Brown, 2011; Meyer, 2013).
Various theories have been proposed to explain how genes
and the environment interact to give rise to complex neuropsy-
chiatric disorders. The “Diathesis-stress” model of schizophrenia,
introduced by Rosenthal D. and Bleuler M. in 1963 (Ingram and
Luxton, 2005) and recently revisited by Fowles (1992), posits that
development of schizophrenia requires both biological vulnera-
bility (diathesis) and stressful life. Weinberger (1987) went on
to propose a similar model in the context of brain development
and maturation, suggesting that an environmental stressor during
early life brain maturation is necessary to trigger the onset of
full-blown psychotic behavior. In the framework of the neurode-
velopmental theory, a “two-hit” model was proposed and two
critical time windows associated with brain early development
and maturation during adolescence were identified as sensitive
periods for exposure to environmental insults that could account
for the emergence of symptoms of schizophrenia (Bayer et al.,
1999; Keshavan, 1999).
However, there is a fundamental gap in our understanding
of the molecular mechanisms by which environmental factors
interact with genetic susceptibility during brain development to
trigger psychosis. A large number of neurodevelopmental animal
models have been developed to investigate the biological basis for
GxE interactions and to evaluate novel pharmacological thera-
pies for their treatment (review, Meyer and Feldon, 2010). For
example, inflammatory responses after infection and cytokine-
mediated effects on brain development have been studied using
polyinosinic:polycytidylic acid (poly I:C) and lipopolysaccharide
(LPS) in rodents; protein deprivation and vitamin D deficiency
to mimic malnutrition; perinatal/postnatal hypoxia models for
obstetric complications; maternal isolation, post-weaning social
isolation/chronic restraint stress have been used to study psy-
chosocial stress effects on brain development. Genetic manip-
ulation of schizophrenia susceptibility genes in rodents, such
as DISC1, NRG1/ErbB4, and COMT has been largely explored
as well.
Interestingly, one of the common findings in both animal
models and postmortem tissue from patients with schizophrenia
is a reduction of the calcium buffer parvalbumin (PV) mRNA
or protein level in cortical fast-spiking (FS) interneurons. PV-
positive interneurons (PVIs), which account for∼40%of the total
cortical Gamma-amminobutyric acid (GABA) ergic interneurons
in rodents (Rudy et al., 2011) and 25% in primates (Condé
et al., 1994) and include basket and chandelier cells, represent
a unique class of interneurons. A significant mRNA reduction
of PV (Hashimoto et al., 2003, 2008; Mellios et al., 2009; Fung
et al., 2010; Volk et al., 2012), GAD67 (Hashimoto et al., 2003;
Curley et al., 2011) or GAT1 (Volk et al., 2012) has been found
in PVIs in the dorsolateral prefrontal cortex of individuals with
schizophrenia. Altered GABA neurotransmission at the synapse
between PV-positive chandelier neurons and the pyramidal cell
axon initial segment (AIS), such as decreased density of chandelier
neuron axon cartridges immunoreactive for GAT-1 (Woo et al.,
1998; Pierri et al., 1999), increased GABAA receptor α2 subunit
at AIS of pyramidal neurons (Volk et al., 2002) and increased
GABAA receptor binding (Benes et al., 1992, 1996), was also
found in schizophrenic patients. Furthermore, factors required
for development of PVI including the transcription factor Lhx6
and brain derived neurotrophic factor (BDNF) and its receptors
are reduced in a subset of individuals with schizophrenia (Cobos
et al., 2006; Liodis et al., 2007; Zhao et al., 2008, see reviews,
Huang et al., 1999; Weickert et al., 2003; Hashimoto et al., 2005;
Weickert et al., 2005; Woo and Lu, 2006; Volk et al., 2012).
Dysfunction of PVIs has been indicated in many neurodevel-
opmental animal models as well. Studies in reverse-translational
models using schizophrenia-risk genes, such as ErbB4 (Fisahn
et al., 2009; Neddens and Buonanno, 2010), DISC1 (Hikida et al.,
2007; Shen et al., 2008; Ayhan et al., 2011), DTNP1 (Ji et al.,
2009; Carlson et al., 2011), BDNF (Sakata et al., 2009) and
glutamate cysteine ligase modifier (GCLM; Steullet et al., 2010;
Cabungcal et al., 2013a), consistently observed a decreased num-
ber or impaired function of PVIs in the hippocampus or cortex.
Also, intensity of PV immunoreactivity and/or loss of PV-positive
cells has been reported in the hippocampus and cortex of mice
with developmental inflammation [prenatal poly I:C injection
(Meyer et al., 2008; Ducharme et al., 2012; Piontkewitz et al.,
2012); neonatal LPS injection (Jenkins et al., 2009)], exposure
to hypoxia (Gerstein et al., 2005; Fagel et al., 2009), chronic
social isolation stress (Harte et al., 2007; Schiavone et al., 2009,
2012; Filipovic et al., 2013), ventral hippocampal lesions (Tseng
et al., 2008; François et al., 2009) or prenatal (E17) methyla-
zoxymethanol acetate (MAM) injections (Lodge et al., 2009; Gas-
tambide et al., 2012). Pharmacological manipulation by NMDA
receptor (NMDAR) antagonists, such as repetitive injection of
ketamine (Behrens et al., 2007), prenatal exposure to MK-801
(Abekawa et al., 2007) or perinatal phencyclidine (PCP) injection
(Wang et al., 2008), all resulted in a decrease in the number of cor-
tical PVIs. These data suggest that PV immunoreactivity and PVI
cells themselves are particularly sensitive to neurodevelopmental
insults.
PVI cell loss and dysfunction have serious consequences for
cortical and hippocampal function. PVIs produce sustained,
high-frequency trains of brief action potentials with large and
fast after-hyperpolarization and little spike frequency adaptation.
They have the lowest input resistance and the fastest membrane
time constant among all interneurons, features that ensure
fast synaptic responses (Connors and Gutnick, 1990; Markram
et al., 2004; Ascoli et al., 2008; Goldberg et al., 2008). FS
PVIs are interconnected via chemical and electrical synapses
(Galarreta and Hestrin, 1999; Gibson et al., 1999) and have a
highly divergent synaptic output to principle neurons (Gulyás
et al., 1999). Inhibitory synapses between PVIs synchronize
action potential activity within basket cell network, whereas
inhibitory synapses between basket cells and principle neurons
distribute this synchronized activity to the principle neuron
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population. Accordingly, multiple lines of evidence indicate that
FS PVIs are essential for the generation of gamma oscillations
(Csicsvari et al., 2003; Hájos et al., 2004; Mann et al., 2005;
Cardin et al., 2009; Sohal et al., 2009), which provides a temporal
structure for information processing and contributes to cognitive
functions including attention (Fries et al., 2001, 2008; Siegel
et al., 2008), perception (Rodriguez et al., 1999) and working
memory (Howard et al., 2003). Cognitive impairments such as
deficits in working memory, attention, and executive function
are particularly evident in patients with schizophrenia (Elvevåg
and Goldberg, 2000), and abnormalities in gamma oscillations
may contribute to these deficits. Schizophrenic patients exhibit
decreases in the power or synchrony of gamma oscillations during
responses to sensory stimulation or cognitive tasks (Gallinat et al.,
2004; Spencer et al., 2004; Symond et al., 2005; Wynn et al., 2005;
Cho et al., 2006; Ford et al., 2007, 2008; Haenschel et al.,
2009; Uhlhaas and Singer, 2010). Thus, abnormalities of FS
PVIs may underlie the cognitive disturbances associated with
schizophrenia.
Considering the substantial evidence for interneuron dysfunc-
tion and NMDAR hypofunction in schizophrenia, we investigated
the impact of NMDAR deletion specifically from interneurons
using a Cre/loxP system in which early postnatal ablation is
restricted to 40–50% of the cortical and hippocampal interneu-
rons, with the majority of cre-targeted cells being PV-positive
[NMDAR (GluN1) knockout mouse strain (Ppp1r2-cre/fGluN1
KO mice; Belforte et al., 2010)]. In this mouse, NMDARs were
functionally eliminated in the early postnatal period (Cre recom-
bination was detectable in the cortex and hippocampus firstly
at postnatal day seven and almost completed by postnatal three
weeks). Reduced GAD67 and PV protein levels and reduced
GABA release were observed from GluN1-depleted interneurons
in mutant animals, and mutant mice exhibited cortical disinhi-
bition evidenced by increased firing of cortical excitatory neu-
rons and reduced neuronal synchrony. At the behavioral level,
this mutant mouse reproduced positive, negative, cognitive and
anxiety-like behavioral phenotypes that resemble the symptoms
of human schizophrenia. Most mutant behavioral phenotypes
were first observed >12 weeks of age, suggesting a latency period
between GluN1 knockout and the emergence of these pheno-
types (Belforte et al., 2010; Nakazawa et al., 2012). Interest-
ingly, social isolation initiated during adolescence exacerbated
the expression of these phenotypes in the mutant (Jiang et al.,
2013).
Importantly, schizophrenia-like pathophysiological and
behavioral phenotypes were not observed when genetic GluN1
ablation in the same subpopulations of GABAergic (gamma-
aminobutyric acid) neurons occurred after adolescence (Belforte
et al., 2010), suggesting that GluN1 deletion is most detrimental
during the postnatal maturation of PVIs. Furthermore, a
prominent increase of oxidative stress was observed in KO mice,
particularly in cortical PVIs, with post-weaning social isolation
sharply exacerbating redox dysfunction. Chronic treatment with
apocynin (APO), an antioxidant and reactive oxygen species
(ROS) scavenger, abolished oxidative stress signs and partially
alleviated schizophrenia-like behavioral phenotypes in KO mice
(Jiang et al., 2013).
In the context of this new data and the substantial evidence for
PVI dysfunction in schizophrenia, we propose that social isolation
in development exacerbates schizophrenia-like phenotypes via
cortical oxidative stress in PVIs (Jiang et al., 2013). These data are
in line with the “diathesis–stress” and neurodevelopmental theo-
ries for the etiology of schizophrenia and suggest that oxidative
stress is one of central factors linking genetic and environmental
risks to GABAergic dysfunction (Figure 1). Below, we discuss in
detail the evidence for the involvement of oxidative stress in the
pathophysiology of schizophrenia, the specific properties of PVIs
that render them vulnerable to oxidative stress, and a potential
molecular pathways which could account for environmentally-
induced oxidative stress in PVIs.
OXIDATIVE STRESS AS A CONVERGENCE POINT FOR
GENETIC AND ENVIRONMENTAL SUSCEPTIBILITY TO
SCHIZOPHRENIA
Growing body of evidence suggests that oxidative stress plays a
significant role in the pathogenesis of schizophrenia (see reviews,
Behrens and Sejnowski, 2009; Do et al., 2009; Yao and Keshavan,
2011). Oxidative stress occurs when ROS or reactive nitrogen
species (RNS) are over-produced or antioxidant defense mech-
anisms fail to counterbalance endogenouse ROS/RNS generated
from normal oxidative metabolism or from pro-oxidant environ-
mental exposure. Excessive ROS or RNS can lead to DNA damage
and membrane damage due to lipid peroxidation and protein
dysfunction.Mammalian antioxidant defense system include ROS
detoxifying enzymes such as superoxide dismutases (SOD), cata-
lase (CAT) and glutathione peroxidase (Gpx), and nonenzymatic
antioxidant components such as albumin, uric acid, bilirubin,
glutathione (GSH), ascorbic acid (vitamin C) and a-tocopherol
(vitamin E). Reduced levels of ROS detoxifying enzymes and
antioxidants have been reported in schizophrenia (Suboticanec
et al., 1990; Reddy et al., 1991; McCreadie et al., 1995; Mukerjee
et al., 1996; Yao et al., 1998, 2000; Do et al., 2000; Ranjekar
et al., 2003; Reddy et al., 2003; Yao et al., 2006; Dadheech et al.,
2008; Raffa et al., 2009; Gawryluk et al., 2011; Coughlin et al.,
2013), in addition to increased levels of lipid peroxides in blood
(Zhang et al., 2006; Al-Chalabi et al., 2009; Padurariu et al., 2010),
platelets (Dietrich-Muszalska et al., 2005), plasma (Mahadik et al.,
1998) and urine (Dietrich-Muszalska and Olas, 2009a). Increased
protein modification has been also demonstrated in plasma
(Dietrich-Muszalska et al., 2009), platelets (Dietrich-Muszalska
and Olas, 2009b) and postmortem brains (Wang et al., 2009).
GENETIC ORIGIN OF OXIDATIVE STRESS
Interestingly, a number of genes involved in antioxidant defense
have been linked to susceptibility for schizophrenia. These include
MnSOD (Akyol et al., 2005), glutathione S-transferases (Saadat
et al., 2007; Nafissi et al., 2011), and a subunit of the key GSH-
synthesizing enzyme GCLM (Tosic et al., 2006; Gysin et al.,
2007, 2011). A mitochondrial DNA sequence variation affecting
a subunit of NADPH-ubiquinone reductase (complex I), a com-
ponent of the electron transport chain responsible for generating
superoxide, has also been associated with schizophrenic patients
and with increased superoxide levels in postmortem brain sam-
ples (Marchbanks et al., 2003). Furthermore, abnormal proteins
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FIGURE 1 | PVIs are vulnerable to oxidative stress induced by GxE during development. An interaction between genetic susceptibility and environ-
mental insults disrupts normal brain development and leads to the manifestation of schizophrenia. Unique properties of PVIs make them vulnerable to redox
imbalance induced by GxE.
encoded by schizophrenia susceptibility genes (PRODH, DISC1,
DAOA, NRG1, G72) cause oxidative stress and/or hypersensitivity
to oxidative stress (Goldshmit et al., 2001; Krishnan et al., 2008;
Drews et al., 2012) or mitochondrial dysfunction (Park et al.,
2010).
OXIDATIVE STRESS INDUCED BY ENVIRONMENTAL INSULTS
In addition to our own evidence for social isolation-induced
oxidative stress, other studies have demonstrated links between
environmental stressors and oxidative stress. ROS elevation was
found after restraint stress (Madrigal et al., 2001; Chakraborti
et al., 2007; Sahin and Gumuslu, 2007), and social isolation
rearing in rats induces behavioral changes akin to schizophrenia,
mediated by an oxidative stress following NADPH oxidase
(Nox-2) elevation in pyramidal neurons (Schiavone et al.,
2009, 2012) or associated with decreased superoxide dismutase
activity and oxidized/reduced glutathione ratio in the cortico-
striatal area (Möller et al., 2011). As in our model, APO
treatment alleviated the signs of oxidative stress and behavioral
deficits following social isolation (Schiavone et al., 2009, 2012).
Furthermore, oxidative stress has been speculated to be an
important downstream mechanism of inflammation-mediated
immune responses. Maternal immune activation by LPS in
rodents triggers oxidative stress (Lanté et al., 2007; Kaneko et al.,
2012; Oskvig et al., 2012), and maternal N-acetyl cysteine (NAC,
a glutathione precursor) treatment prevents LPS-induced adverse
developmental outcomes including elevation of cytokines in
maternal and fetal compartments (Xu et al., 2005; Beloosesky
et al., 2006), fetal death, preterm labor (Buhimschi et al., 2003),
hypomyelination (Paintlia et al., 2004), and impairments in
spatial memory and hippocampal long-term potentiation in
the offspring (Lanté et al., 2007). Protein malnutrition (Feoli
et al., 2006a,b) and hypoxia (Dafre et al., 2003; Sheldon et al.,
2008; Niatsetskaya et al., 2012) can also increase oxidative
stress.
GxE-INDUCED OXIDATIVE STRESS
A number of studies have investigated whether prenatal and/or
postnatal environmental insults interact with specific genetic fac-
tors to cause oxidative stress and increase the risk of long-lasting
neurodevelopmental brain dysfunction. Using mice which exi-
hibit a 60–70% reduction in GSH due to ablation of the GCLM
gene, Kim Q. Do and her colleagues have shown that impaired
GSH synthesis is associated with morphological, neurochemi-
cal anomalies and behavioral phenotypes similar to those in
schizophrenia patients (Steullet et al., 2010; Kulak et al., 2012).
They also found elevated oxidative stress indicated by increased
levels of 8-oxo-7, 8-dihydro-2′-deoxyguanosine (8-OH-dG), a
marker of oxidized DNA, in ventral hippocampus and anterior
cingulate cortex (Steullet et al., 2010; Cabungcal et al., 2013a).
An exogenous dopamine stress induced by a dopamine reuptake
inhibitor, GBR-12909, led to exacerbated 8-OH-dG labeling in the
anterior cingulate cortex of GCLM KO mice but not wild-type
mice. Treatment with NAC fully prevented the increase in 8-OH-
dG labeling induced by GBR-12909 in KO mice (Cabungcal et al.,
2013a).
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In light of our recent study indicating an interaction between
NMDAR hypofunction and oxidative stress (Jiang et al., 2013),
it is important to note that the relationship of NMDAR hypo-
function to oxidative stress was initially observed in the rodent
models treated with NMDAR antagonists. Chronic perinatal PCP
administration reduced glutathione levels and produced long-
term alteration of antioxidant defense in the corticolimbic areas
of the rat brain (Radonjic et al., 2010). Similarly, repetitive expo-
sure to ketamine, another NMDAR antagonist, activated the
superoxide-producing enzyme Nox-2 in mouse brains (Behrens
et al., 2007; Zhang et al., 2008). Elevation of cortical ROS level was
also found in our Ppp1r2-cre/fGluN1 KO mice when NMDAR
was eliminated in cortical PVIs during early postnatal period.
Interestingly, post-weaning social isolation sharply exacerbated
ROS level in KO mice. Chronic treatment with APO abolished
oxidative stress signs and partially alleviated schizophrenia-like
behavioral phenotypes in KOmice. These indicated that oxidative
stress does contribute to behavioral impairments of this mutant
line and social isolation exacerbated schizophrenia-like pheno-
types via cortical oxidative stress (Jiang et al., 2013).
PV INTERNEURON-SPECIFIC VULNERABILITY TO OXIDATIVE
STRESS
It has been observed in several lines of animal studies that PVIs
are vulnerable to oxidative stress during development. Behrens
et al. (2007, 2008) found that repetitive adult exposure to the
NMDAR antagonist ketamine increases the levels of the proin-
flammatory cytokine interleukin-6 (IL-6) in brain which, through
activation of the superoxide-producing enzyme Nox-2, leads to
the loss of the GABAergic phenotype of PVIs. Pretreatment of
animals with APO, or with the SOD-mimetic C3 reduces super-
oxide production and prevents the loss of PV immunoreac-
tivity (IR) induced by ketamine. Nox-2 deficiency completely
prevented the loss of PVIs in the prelimbic regions (Behrens
et al., 2008). The reversible effects in adult exposure (Behrens
et al., 2008) were not observed for the animals with perinatal
exposure of ketamine, suggesting that perturbation of the excita-
tory/inhibitory balance during early life produces oxidative stress
that has profound effect on PVI maturation. In fact, exposure of
wild type mice to ketamine on postnatal day 7, 9, and 11 is suf-
ficient to cause a reduction in PV-IR in adulthood without death
of interneurons (Powell et al., 2012), suggesting that blockade of
NMDAR signaling is sufficient to alter the expression profile of FS
interneurons.
The idea that PVIs are more susceptible to oxidative stress dur-
ing development is also supported by the evidence that early post-
natal PCP injection can selectively reduce PVI numbers (Wang
et al., 2008; Nakatani-Pawlak et al., 2009) and cause redox dysreg-
ulation (Radonjic et al., 2010) in corticolimbic areas. Cabungcal
et al. (2007) showed that a transient brain GSH deficit induced
by BSO (Lbuthionine-(S, R)-sulfoximine) during early postnatal
period is sufficient to cause cognitive impairment as well as
decreased numbers of PVIs in adulthood. Using GCLM KOmice,
Cabungcal et al. (2013a) demonstrated that impaired synthesis of
glutathione delays maturation of PVIs in the anterior cingulate
cortex as indicated by reduced PVI numbers, but not calre-
tinin and calbidin positive interneuron numbers, and a reduction
in the density of perineuronal nets (PNNs), specialized extra-
cellular matrix components concentrated around PVIs. These
effects of reduced glutathione synthesis were only evident during
early development but not in later stages. More interestingly,
they found that an additional oxidative challenge induced by
the dopamine reuptake inhibitor GBR-12909 in preweaning or
pubertal but not in young adult GCLM KO mice reduces the
number of PVIs in anterior cingulate cortex. Additionally, PVIs
in rats with a neonatal central hippocampal lesion exhibit oxida-
tive stress prior to symptom onset as indicated by increased 8-
OH-dG marker intensity in most PVIs in the prefrontal cortex
(O’Donnell, 2012). Treatment with the GSH precursor NAC
during juvenile and adolescent periods reverses the loss of PVIs
and restores deficits in prepulse inhibition (O’Donnell, 2012).
Collectively, these data suggest that PVIs are vulnerable to oxida-
tive stress, particularly during their development. In our Ppp1r2-
cre/fGluN1 KO mice, we observed the reduction of PV-IR and
oxidative stress increase on cortical PVIs, not calretinin or cal-
bidin positive interneurons, following the post-weaning social
isolation. Reduction of PV-IR upon social isolation was pre-
vented by chronic treatment of APO, suggesting that reduced PV
protein level is associated with elevated oxidative stress in PVIs
(Jiang et al., 2013).
POSTNATAL DEVELOPMENT AND MATURATION OF FAST-SPIKING PVIs
Specific vulnerability of PVIs to developmental stressors that
cause oxidative stress could result from their relatively late time
course of maturation. The mammalian GABAergic system devel-
ops slowly during early postnatal life; in the neonatal brain, GABA
is the principal excitatory transmitter that induces depolariza-
tion and that are important for the early development of the
neural network (Ben-Ari et al., 2004). Conversion of GABAergic
transmission from depolarizing to hyperpolarizing during the
first postnatal week in rodents depends on the expression of the
K+/Cl- cotransporter (KCC2) and the Cl- electrochemical poten-
tial (Ben-Ari et al., 2004, 2012). GABA signaling not only regulates
interneuron axon branching and synapse formation during the
maturation of inhibitory innervations (Chattopadhyaya et al.,
2007) but also regulate synapse elimination and axon pruning
(Wu et al., 2012).
Studies on multiple mammalian species have shown that
cortical FS PVIs develop dramatically during early postnatal life.
In rodents, transcriptional and electrophysiological maturation
of neocortical FS interneurons from slow (low gamma band
frequency) into fast (upper gamma band) signaling devices
occurs over the first four weeks (Doischer et al., 2008; Okaty
et al., 2009; Goldberg et al., 2011). PVIs start to express
parvalbuminmRNA and protein by postnatal first week (de Lecea
et al., 1995; Itami et al., 2007). The electrochemical properties
of PVIs change around the same developmental age; the K+
channel subunits Kv3.1 and Kv3.2, sodium channels Scn8a and
Scn4b, and two-pore K+ leak channels TWIK1 and TASK1 are
developmentally regulated and contribute to the establishment
of the FS behavior characteristics of PVIs (Du et al., 1996; Rudy
and McBain, 2001; Tansey et al., 2002; Grieco and Raman,
2004; Grieco et al., 2005; Levin et al., 2006; Okaty et al., 2009;
Goldberg et al., 2011). It was also found that the synaptogenesis
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of both electrical and GABAergic connections among FS PVIs
and PVI-pyramidal neuron microcircuit in rodent was not
established until the second postnatal week (Pangratz-Fuehrer
and Hestrin, 2011; Yang et al., 2012), and maturation of
perisomatic innervations by PVIs is activity and experience
dependent (Chattopadhyaya et al., 2004; Jiao et al., 2006).
Mature PVIs are wrapped by PNNs, and removal of PNNs
increased the excitability of interneurons (Dityatev et al., 2007).
Recently it was revealed that PNNs protected mature PVIs
against oxidative stress and excessive ROS challenge during
early life disrupted PNNs maturation around PVIs and made
them more susceptible to oxidative stress (Cabungcal et al.,
2013b).
A critical period for PVI maturation is adolescence. Studies
in rodents, primates and human subjects indicate that expres-
sion of PV protein or mRNA and the density of PVIs processes
increase during the pre-pubertal period, peaking during adoles-
cence (Anderson et al., 1995; Erickson and Lewis, 2002; Fung
et al., 2010; Caballero et al., 2013). FS PVIs in PFC undergo
dramatic changes in the composition of glutamatergic recep-
tors during adolescence: the NMDA/AMPA ratio is dramatically
decreased in adolescence, but returns to juvenile levels in adults
(Wang and Gao, 2009) and more FS PVIs express calcium perme-
able AMPA receptors during adolescence (Wang and Gao, 2010).
Dopamine modulation of FS PVIs changes dramatically dur-
ing adolescence (Tseng and O’Donnell, 2007; O’Donnell, 2010,
review). Interestingly, in a human study, Uhlhaas et al. (2009)
found that cortical networks undergo a transient destabilization
from late adolescence to early adulthood, reflected by signifi-
cant reductions of phase synchrony and induced gamma-band
power.
THE HIGH ENERGY DEMAND OF PVIs
The majority of PVIs are FS (86%, Pawelzik et al., 2002) and
PVIs receive extremely dense excitatory innervations (Gulyás
et al., 1999), suggesting that PVIs are often in a depolarized
state. As a consequence of intense neuronal firing, the constant
requirement for maintenance of sodium and potassium balance
puts a high demand on cellular energetics. Consistent with this
idea, PVIs have particularly larger numbers of mitochondria and
higher cytochrome c content than other neurons (Gulyás et al.,
2006). Also, it was recently reported that gamma oscillations are
also especially energy demanding and require both high level of
complex I and strong functional performance of mitochondria.
Kann et al. (2011) found that the amount of oxygen consumption
of gamma oscillations reaches that of seizure-like events, and
gamma oscillations utilize mitochondrial oxidative capacity near
limit. Groups of studies indicated that gamma oscillations are
exquisitely sensitive to mitochondrial dysfunction (Fano et al.,
2007; Huchzermeyer et al., 2008; Hájos et al., 2009; Pietersen
et al., 2009; Whittaker et al., 2011) under conditions with a
variety of mitochondrial respiratory chain inhibitors through
an effect on FS interneurons. Interestingly, Kann et al. (2011)
found that gamma oscillation power, oxygen consumption and
complex I subunits are particularly higher in hippocampal sub-
field CA3. Kim Q. Do and her colleagues observed a selective
increase of oxidative stress and a decrease of PV-IR interneu-
rons in ventral CA3/DG in GCLM KO mice with a deficit of
antioxidant capacity in the brain (Steullet et al., 2010). This
may be related to particularly high energy demanding in these
areas.
In line with a high metabolic rate of PVIs, these neurons (and
transcription of PV itself) are especially vulnerable to stimuli
that compromise mitochondrial function. For example, PVIs in
the striatum are sensitive to 6-hydroxydopamine (Salin et al.,
2009), quinolic acid (Giampà et al., 2006), rotenone (Lapointe
et al., 2004), and methamphetamine (Zhu et al., 2006) and
developmental injections of 3-nitropropionic acid (3-NP) cause
a long-term loss of PV protein (Gibson and Clowry, 2003). Of
particular interest is the vulnerability of cortical, hippocampal,
and striatal PVIs to perinatal anoxia/hypoxia (Dell’Anna et al.,
1996; Van de Berg et al., 2003; Gerstein et al., 2005; Wang et al.,
2011) and global ischemia (Guan et al., 2000; Meade et al.,
2000), considering that perinatal complications and/or hypoxia
could be significant environmental factors contributing to the
development of schizophrenia.
PGC-1α AS A MOLECULAR TARGET OF PVI-SPECIFIC GxE
Recent evidence suggests that a critical regulator of antioxidant
capacity in PVI could be the transcriptional coactivator per-
oxisome proliferator activated receptor gamma (PPARgamma)
coactivator 1α (PGC-1α).
PGC-1α DRIVES DEVELOPMENTAL TRANSCRIPTIONAL PROGRAMS FOR
INCREASED ANTIOXIDANT CAPACITY, PARVALBUMIN
TRANSCRIPTION, AND MITOCHONDRIAL FUNCTION
PGC-1α, initially coined the “master regulator of metabolism,”
is highly expressed in tissues with high energy demands, such
as brown adipose tissue, heart, liver, skeletal muscle and brain
(Puigserver et al., 1998). It has been found to serve as a central
component of the transcriptional regulatory circuity that coordi-
nately controls the energy-generating functions of mitochondria
(Figure 2). It is capable of driving transcriptional control of mito-
chondrial biogenesis through direct interaction with, and coac-
tivation of, PPARs (Madrazo and Kelly, 2008), estrogen-related
receptors (ERRs; Schreiber et al., 2004; Eichner and Giguère,
2011), nuclear respiratory factors (NRF-1/NRF-2; Wu et al., 1999;
Scarpulla, 2011) and the transcription factor yin-yang one (YY1;
Basu et al., 1997; Seelan and Grossman, 1997; Cunningham et al.,
2007; Xi et al., 2007), which are important nuclear transcription
factors controlling mitochondrial metabolism (Scarpulla et al.,
2012). PGC-1α is also an inducible responder to cellular energetic
and metabolic stress, such as cold exposure (Puigserver et al.,
1998; Uldry et al., 2006; Fisher et al., 2012), nutrient deprivation
(Herzig et al., 2001; Yoon et al., 2001; Handschin et al., 2005;
Rhee et al., 2006) and exercise (Baar et al., 2002; Handschin and
Spiegelman, 2008) and is dynamically regulated in response to a
variety of signaling pathways involved in cellular growth, differ-
entiation and energy metabolism. Additionally, a large amount
of evidence suggests that PGC-1α links mitochondrial biogenesis
and the response to oxidative stress. PGC-1α has been shown to
be a powerful regulator of ROS metabolism (St-Pierre et al., 2006;
Cunningham et al., 2007).
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FIGURE 2 | PGC-1α is a critical contributor to the antioxidant capacity of
FS PVIs. The high energy demand of FS PVIs makes them vulnerable to
mitochondrial dysfunction and oxidative stress. PGC-1α, a master regulator of
transcriptional programs involved in mitochondrial energy metabolism and
antioxidant defense, is highly concentrated in PVIs. In concert with other
proteins, PGC-1α increases the transcription of antioxidant enzymes and PV.
Transcription of PGC-1α itself is intracellular Ca2+ influx-dependent and can be
regulated by epigenetic modifications.
In the central nervous system, PGC-1α protein is expressed
most highly in GABAergic neurons (Cowell et al., 2007) with
a particularly high concentration in cortical PVIs (Jiang et al.,
2013). Reductions in PGC-1α mRNA or protein level and its
activity have been implicated in several neurodegenerative dis-
eases, such as Huntington (Cui et al., 2006; Weydt et al., 2006),
Alzheimer’s (Qin et al., 2009), and Parkinson’s Disease (Zheng
et al., 2010; Shin et al., 2011). A complete absence of PGC-1α
in mice causes profound motor impairment and spongioform
neurodegeneration in the striatum and cortex (Lin et al., 2004)
by six weeks of age that is entirely attributable to a loss of PGC-
1α in the central nervous system (Lucas et al., 2012). Of note,
motor impairments are still observed in PGC-1α heterozygous
mice, albeit to a lesser extent (Lucas et al., 2012); it is possible that
the heterozygousmice would provide a better model to investigate
the relevance of PGC-1α reductions for understanding its roles in
pathophysiology.
The neuroprotective effect of endogenous PGC-1α has
been explored in multiple different studies. Mice lacking
PGC-1α are more sensitive to neurodegeneration induced
by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)
and kainic acid, and this degeneration was associated with
greater levels of stable markers of oxidative damage, such as
nitrotyrosylation of proteins and 8-OH-dG in DNA. Elevation
of PGC-1α levels above those of wild-type nerve cells give
an increased resistance to death by the oxidative stressors
H2O2 and paraquat (St-Pierre et al., 2006), and overexpression
of PGC-1α in culture increases mitochondrial density and
ATP levels (Wareski et al., 2009), drives the expression of
transcripts involved in antioxidant defense, glucose transport,
and mitochondrial fusion and protects cells from hydrogen
peroxide-induced cell death and caspase-3 activation (Cowell
et al., 2009). In the context of NMDAR activation (Hardingham
and Bading, 2010), knock-down of endogenous PGC-1α
mediated by siRNA increases extrasynaptic NMDAR(EX)
activity and vulnerability to excitotoxic insults in rat cortical
neurons, while exogenous expression of PGC-1α cDNA results
in a neuroprotective reduction of extrasynaptic currents
without affecting synaptic NMDAR activity (Puddifoot et al.,
2012).
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Interestingly, PGC-1α protein is selectively localized to
interneuron nuclei by the second week of postnatal life in
rodent brain (Cowell et al., 2007), although its mRNA and
protein are observed in neurons throughout the embryonic
forebrain. This temporal pattern of expression coincides with the
postnatal developmental switch of GABA from an excitatory to
inhibitory neurotransmitter and the developmental induction
of PV. In fact, mice lacking PGC-1α are deficient in PV-IR,
without a loss of other interneuron markers such as GAD67,
GAD65, calbindin, calretinin, cholescystokinin and somatostatin
(Lucas et al., 2010). Changes in mRNA level of the PVI specific
potassium channel Kv3.1 were not observed, either, suggesting
that FS interneurons are intact in PGC-1α null mice, just lacking
expression of PV protein. Furthermore, overexpression of PGC-
1α cDNA in neuroblastoma cells robustly induces transcription
of PV promoter, implicating PGC-1α as a critical factor for the
developmental induction of PV gene transcription in cortical
PVIs. In support of this hypothesis, we found substantial overlap
of PV and PGC-1α mRNA in the cortex, with almost all PV
mRNA-containing cells being PGC-1α mRNA-positive in S1
cortex and most of the total population of PGC-1α mRNA
positive cells being PV mRNA-positive (Jiang et al., 2013). These
observations raise the possibility that PGC-1α coordinately
regulates programs of gene expression for the developmental
induction of PV and an increased antioxidant capacity in PVIs
(Figure 2).
With this in mind, we investigated whether PGC-1α mRNA
or protein is affected by the developmental deletion of NMDARs
in our Ppp1r2-cre/fGluN1 KO mice (Jiang et al., 2013). Cortical
PGC-1αmRNA and protein levels were down-regulated and post-
natal social isolation exacerbated the reduction. In addition to a
reduction in PV-IR, mutant mice exhibited a reduction in mRNA
levels of several key ROS-detoxifying enzymes including CuZn-
SOD, MnSOD, CAT and Gpx, and an impairment in antioxidant
capacity and cortical oxidative stress. All these results suggest that
PGC-1α plays a critical role in PVI antioxidant capacity that could
have relevance for the understanding of schizophrenia patho-
physiology. While it is currently not known whether PGC-1α
expression is affected in schizophrenia, genetic association studies
on chromosome 4p implicated the PGC-1α gene locus in bipolar
disorder and schizophrenia (Blackwood et al., 1996; Christoforou
et al., 2007, 2011). Integration of genetic data across human and
murine studies also suggests PGC-1α as a potential susceptibility
gene for anxiety-related disorders (Hettema et al., 2011).
Concerning the potential roles for PGC-1α in the maintenance
of mitochondrial function, there is substantial evidence for
mitochondrial dysfunction in schizophrenia. Using 31phosphorus
magnetic resonance spectroscopy (31P-MRS) to measure ATP
and phospholipids (Fujimoto et al., 1992; Volz et al., 1997), and
positron emission tomography (PET) scans with [18F]-fluoro-
deoxy-glucose (FDG; Buchsbaum and Hazlett, 1998), altered
energy metabolism has been observed in cerebral cortex of
schizophrenic patients. A significant decrease in mitochondria
number and density in the prefrontal cortex and caudate
nucleus of postmortem brains of subjects with schizophrenia was
observed compared with control subjects (Uranova et al., 2001).
A lower number of mitochondria were found in medication-
free patients compared with those taking antipsychotics or
control medications, suggesting drug treatment normalizes the
number of mitochondria (Inuwa et al., 2005). Combining a
parallel transcriptomics, proteomics and metabomics approach,
Prabakaran et al. (2004) explored the molecular signatures
in brain tissue of schizophrenia. Almost half of the altered
proteins identified were associated with mitochondrial function
and oxidative stress responses. Critical role of PGC-1α in
mitochondrial biogenesis and metabolism highlights it as
an interesting candidate for further study in the context of
schizophrenia.
POTENTIAL BIOLOGICAL MECHANISMS UNDERLYING CONVERGENCE
OF GxE ON PGC-1α
It is notable in our study that no significant change in PGC-
1α mRNA or protein level in Ppp1r2-cre/fGluN1 KO mice was
observed until the post-adolescent period (eight week old). Post-
weaning social isolation exacerbated the reduction of PGC-1α
only in KO mice. This implicates that PGC-1α, as a master
regulator of mitochondria energymetabolism and anti-oxidation,
with a selective expression pattern in FS PVI, could be a potential
converging factor for GxE. However, the mechanisms by which
GxE regulate PGC-1α transcription and trigger oxidative stress
on PVIs remains to be clarified.
Early postnatal NMDAR hypofunction in cortical PVI
Notably, PGC-1α transcription and activity itself can be regulated
by alterations in intracellular calcium concentrations and the acti-
vation of calcium calmodulin-dependent kinase IV (Handschin
et al., 2003) that often occur with activation of the NMDAR. In
fact, in neurons, transcription of PGC-1α is activity-dependent
(Liang and Wong-Riley, 2006; Meng et al., 2007; Yu and Yang,
2010) and increased by NMDAR activation (Lee et al., 2007; Luo
et al., 2009; Liang et al., 2010; Figure 2). Thus, it is not surprising
that early postnatal KO of NMDAR in PVIs is associated with a
down-regulation of PGC-1α.
Epigenetic regulation of PGC-1α
Another mechanism of PGC-1α regulation that could account
for environmental and genetic convergence on PVIs may be
the modulation of PGC-1α transcription and/or activity by epi-
genetic mechanisms. Increasing evidence suggests that external
environmental factors, such as nutritional, chemical, physical,
even psychosocial factors can modify gene expression through
epigenetic processes (Jirtle and Skinner, 2007). Epigenetics refers
to a set of mitotically heritable and reversible changes in gene
expression that occur without a change in the genomic DNA
sequence. Epigenetic changes have been associated with a number
of paradigms involving social behavior in animal models, such as
maternal care (Weaver et al., 2004), early life adversity (Murga-
troyd et al., 2009), animal models of posttraumatic stress disorder
(PTSD; Chertkow-Deutsher et al., 2010) and chronic social defeat
(Tsankova et al., 2006).
Furthermore, epigenetic changes in interneuron-specific
transcripts have been documented in schizophrenia; a significant
reduction of GABAergic protein (GAD67 and reelin) are
accompanied by increased methylation of the GAD67 and Reelin
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promoters and increased DNA methyltransferase (DNMT) one
in the same interneurons in the cortex of schizophrenic patients
(Guidotti et al., 2000; Grayson et al., 2005; Veldic et al., 2005;
Huang et al., 2007; Ruzicka et al., 2007). Mill et al. (2008)
published the first epigenome-wide study of psychosis using
postmortem tissue obtained from frontal cortex of patients
with schizophrenia or bipolar disorders. This study enriched the
unmethylated fraction of genome DNA and used a CpG island
microarray to assay DNA methylation at approximately 12,000
sites across the genome. Their gene-ontology analysis highlights
epigenetic disruption to loci involved in mitochondrial function,
stress response and brain development.
Recently, another study utilizing genome-wide methylation
profiling of blood samples from monozygotic twins discordant
for schizophrenia linked aberrant DNA methylation of PGC-
1α gene to schizophrenia (Dempster et al., 2011). Indeed, one
CRE (CREB binding site) was found in mouse PGC-1α pro-
moter region and it encompassed a CpG site (Figure 2). It
has been reported that methylation of CpG in CRE blocked
pCREB binding (Iguchi-Ariga and Schaffner, 1989; Sunahori
et al., 2009). CREB is an important regulator for PGC-1α gene
transcription (Herzig et al., 2001; St-Pierre et al., 2006). Barrès
et al. (2009) provided evidence that PGC-1α hypermethylation
is concomitant with reduced mitochondrial content in type 2
diabetic patients, and links DNMT3B to the acute fatty-acid-
induced non-CpG methylation of PGC-1α promoter. Although
studies by Dempster et al. (2011) and others assessed PGC-1α
methylation status in peripheral samples, and the methylation
response in peripheral cells may not accurately reflect methylation
status in the brain (Provençal et al., 2012), these data suggest
that a differential epigenetic response does occur on PGC-1α in
schizophrenic individuals compared with normal subjects. There
is also evidence that PGC-1α gene expression and activity are
influenced directly by inhibitors of histone deacetylases (HDACs),
enzymes that epigenetically modify histones to block transcrip-
tion. Overexpression of HDAC5 reduces PGC-1α in the heart
(Czubryt et al., 2003) by blocking the developmental induction
of PGC-1α by myocyte enhancing factor 2 (MEF2), and exposure
of neuroblastoma cells to the HDAC inhibitors trichostatin A
or valproic acid (a mood stabilizer given as adjunct therapy to
schizophrenia patients) increases mRNA level of PGC-1α and
its target gene glucose transporter four (Cowell et al., 2009).
Hypoxia exposure itself can cause an increase in the expression
of the DNA methylating enzymes DNMT1 and DNMT3b mRNA
that is sustained in adulthood and accompanied by increased
methylation of the SOD2 promoter (Nanduri et al., 2012); taking
into account the role of PGC-1α in tissue responses to hypoxia
(Arany et al., 2008; Zhu et al., 2010; Pino et al., 2012; Zhao
et al., 2012), it is attractive to speculate that environmental stimuli
can modulate PGC-1α-dependent pathways and PVI antioxidant
capacity by epigenetic mechanisms.
Hypothalamic-pituitary-adrenocortical (HPA) hyperactivity
by social isolation/stress could involve into PGC-1α regulation
through epigenetic mechanisms as well. Activation of the HPA
axis represents a common reaction to many environmental
insults, including infection, malnutrition, hypoxia, and
psychosocial stress (Oitzl et al., 2010). Most of rodent studies
showed that chronic early life social isolation is associated
with higher basal levels of glucocorticoids and increased HPA
response to acute stressors (Weiss et al., 2004; Chida et al., 2005;
Perelló et al., 2006; Ruscio et al., 2007; Williams et al., 2009;
Weintraub et al., 2010; Toth et al., 2011). Glucocorticoids have
been reported to influence DNA methylation in genes containing
glucocorticoid response elements (GREs), such as fkbp5 and
tyrosine hydroxylase gene (Lee et al., 2011; Niwa et al., 2013).
Studies in early postnatal maternal care/separation have linked
epigenetic mechanisms with alteration of genes involved in the
regulation of the HPA axis. Early life experience influences DNA
methylation state of glucocorticoid receptor (GR) gene in human
studies (Oberlander et al., 2008; McGowan et al., 2009; Labonte
et al., 2012) and animal models (see review by, Weaver, 2009).
Epigenetic-mediated changes in GR could contribute to PGC-1α
alteration. Further studies need to be done to clarify how GxE
influence the transcription of PGC-1α and PV and antioxidant
capacity in cortical PVIs.
SUMMARY
The interaction between genes and environment (GxE) has been
postulated to be critical to trigger the onset of schizophrenia.
Epidemiological observations and neuropathological studies all
support that schizophrenia is a consequence of abnormal brain
development. As an essential player in the generation of gamma
oscillations, corticolimbic PVIs have a key role in higher cog-
nitive processing. Considering the evidence for PVI dysfunc-
tion in patients with schizophrenia and in various neurodevel-
opmental animal models, the vulnerability of PVIs during early
life development and the mechanisms by which these neurons
respond to environmental stimuli are particularly relevant for our
understanding of schizophrenia pathophysiology. Here, we pre-
sented evidence for a convergence of genetic and environmen-
tal factors on oxidative stress in PVIs and suggest that PGC-1α
is a critical regulator of PV transcription and antioxidant capac-
ity in these neurons. The delayed maturation during postnatal
period and high energy demanding of FS PVIs make them sus-
ceptible to environmental insults, particularly redox imbalance,
during early life experience. Oxidative stress could be one of
the important mechanisms integrates GxE on PVIs disturbance.
PGC-1α, as a master regulator of mitochondrial metabolism,
which is highly and selectively expressed in PVIs, could be one
of the key factors responsible for the antioxidant capacity of
PVIs. Our study using NMDAR hypofunction animal model
revealed that redox dysregulation due to a decrease in PGC-
1α abundance in cortical parvalbumin interneurons exacerbated
schizophrenia-like phenotypes following social isolation stress.
This implicates PGC-1α as a potential converging factor for GxE.
Further studies on the impact of GxE on PGC-1α transcription
and function would not only help identify neuropathophysio-
logical mechanism underlying GxE in schizophrenia, but impor-
tantly, aid in the development of targeted interventions for this
illness.
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